A comparative study on immunomodulatory activity of polysaccharides from two official species of ganoderma (Lingzhi)

Nutrition and Cancer

Volumn 66, Issue 7, 2014, Pages 1124-1131

  Meng, Lan Zhen ^a   Xie, Jing ^a   Lv, Guang Ping ^a   Hu, De Jun ^a   Zhao, Jing ^a   Duan, Jin Ao ^b   Li, Shao Ping ^a  

^a University of Macau   (Macao)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOTOXIN; FUCOSE; GALACTOSE; GLUCOSE; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MANNOSE; NITRIC OXIDE; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CARBOHYDRATE ANALYSIS; CELL FUNCTION; CELL KILLING; CELL VIABILITY ASSAY; COMPARATIVE STUDY; GANODERMA; GANODERMA LUCIDUM; GANODERMA SINENSE; GAS CHROMATOGRAPHY; HELPER CELL; IMMUNOMODULATION; IMMUNOSURVEILLANCE; IN VITRO STUDY; MACROPHAGE FUNCTION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN DETERMINATION; PROTEIN SECRETION; QUALITY CONTROL; SPECIES IDENTIFICATION; STRUCTURE ACTIVITY RELATION; ANIMAL; CELL SURVIVAL; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; MACROPHAGE; METABOLISM; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; GANODERMA; IMMUNOMODULATION; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; MACROPHAGES; MICE; MOLECULAR WEIGHT; NITRIC OXIDE; PHAGOCYTOSIS; POLYSACCHARIDES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908133865     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.948215     Document Type: Article

References (57)

1. Nie S., Zhang H., Li W., and Xie M.: Current development of polysaccharides from Ganoderma: Isolation, structure and bioactivities. Bioact Carbohyd Diet Fibre 1, 10-20, 2013.
2. Chinese Pharmacopoeia Commission.: Chinese Pharmacopoeia. China Medical Science Press, Beijing, China, 2010.
3. Liu Y., Qiu F., and Di X.: Sensitive and selective liquid chromatography-tandem mass spectrometry method for the determination of five ganoderic acids in Ganoderma lucidum and its related species. J Pharm Biomed Anal 54, 717-721, 2011.
4. Liu YW., Gao JL., Guan J., Qian ZM., Feng K, et al.: Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines. J Agric Food Chem 57, 3087-3093, 2009.
5. Yan YZ., Xie PS., Lam WK., Chui E., and Yu QX.: Study on triterpenoic acids distribution in Ganoderma mushrooms by automatic multiple development high performance thin layer chromatographic fingerprint analysis. J AOAC Int 93, 1384-1389, 2010.
6. Zhao J., Zhang XQ., Li SP., Yang FQ., Wang YT, et al.: Quality evaluation of Ganoderma through simultaneous determination of nine triterpenes and sterols using pressurized liquid extraction and high performance liquid chromatography. J Sep Sci 29, 2609-2615, 2006.
7. Gao JL., Leung KSY., Wang YT., Lai CM., Li SP, et al.: Qualitative and quantitative analyses of nucleosides and nucleobases in Ganoderma spp. by HPLC-DAD-MS. J Pharm Biomed Anal 44, 807-811, 2007.
8. Lv GP., Zhao J., Duan JA., Tang YP., and Li SP.: Comparison of sterols and fatty acids in two species of Ganoderma. Chem Cent J 6, 10, 2012.
9. Yue GGL., Fung KP., Tse GMK., Leung PC., and Lau CBS.: Comparative studies of various Ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J Altern Complement Med 12, 777-789, 2006.
10. Cheng CH., Leung AY., and Chen CF.: The effects of two different Ganoderma species (Lingzhi) on gene expression in human monocytic THP-1 cells. Nutr Cancer 62, 648-658, 2010.
11. Boh B.: Ganoderma lucidum: A potential for biotechnological production of anti-cancer and immunomodulatory drugs. Recent Pat Anticancer Drug Discov 8, 255-287, 2013.
12. Zhang S., Nie S., Huang D., Li W., and Xie M.: Immunomodulatory effect of Ganoderma atrum polysaccharide on CT26 tumor-bearing mice. Food Chem 136, 1213-1219, 2013.
13. Li WJ., Chen Y., Nie SP., Xie MY., He M, et al.: Ganoderma atrum polysaccharide induces anti-tumor activity via the mitochondrial apoptotic pathway related to activation of host immune response. J Cell Biochem 112, 860-871, 2011.
14. Liu Y., Li YF., Zheng KY., and Fei XF.: Antitumor active protein-containing glycans from the body of Ganoderma tsugae. Chem Res Chin Univ 28, 449-453, 2012.
15. Ma J., Liu C., Chen Y., Jiang J., and Qin Z.: Cellular and molecular mechanisms of the Ganoderma applanatum extracts induces apoptosis on SGC-7901 gastric cancer cells. Cell Biochem Funct 29, 175-182, 2011.
16. Jeong YT., Yang BK., Jeong SC., Kim SM., and Song CH.: Ganoderma applanation: A promising mushroom for antitumor and immunomodulating activity. Phytother Res 22, 614-619, 2008.
17. Lin CH., Hsiao YM., Ou CC., Lin YW., Chiu YL, et al.: GMI, a Ganoderma immunomodulatory protein, down-regulates tumor necrosis factor α-induced expression of matrix metalloproteinase 9 via NF-B pathway in human alveolar epithelial A549 cells. J Agric Food Chem 58, 12014-12021, 2010.
18. Hsin IL., Ou CC., Wu TC., Jan MS., Wu MF, et al.: GMI, an immunomodulatory protein from Ganoderma microsporum, induces autophagy in non-small cell lung cancer cells. Autophagy 7, 873-882, 2011.
19. Lin CH., Sheu GT., Lin YW., Yeh CS., Huang YH, et al.: A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochem 45, 1537-1542, 2010.
20. Wu GS., Guo JJ., Bao JL., Li XW., Chen XP, et al.: Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum-a review. Expert Opin Investig Drugs 22, 981-992, 2013.
21. Sliva D.: Ganoderma lucidum in cancer research. Leukemia Res 30, 767-768, 2006.
22. Xu Z., Chen X., Zhong Z., Chen L., and Wang Y.: Ganoderma lucidum polysaccharides: Immunomodulation and potential anti-tumor activities. Am J Chin Med 39, 15-27, 2011.
23. Zhou X., Lin J., Yin Y., Zhao J., Sun X, et al.: Ganodermataceae: Natural products and their related pharmacological functions. Am J Chin Med 35, 559-574, 2007.
24. Sheena N., Lakshmi B., and Janardhanan KK.: Therapeutic potential of Ganoderma lucidum (Fr.) P. Karst. Nat Prod Rad 4, 382-386, 2005.
25. Lin YL., Liang YC., Lee SS., and Chiang BL.: Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-B and p38 mitogen-activated protein kinase pathways. J Leukocyte Biol 78, 533-543, 2005.
26. Yeh CH., Chen HC., Yang JJ., Chuang WI., and Sheu F.: Polysaccharides PS-G and protein LZ-8 from Reishi (Ganoderma lucidum) exhibit diverse functions in regulating murine macrophages and T lymphocytes. J Agric Food Chem 58, 8535-8544, 2010.
27. Lai SW., Lin JH., Lai SS., and Wu YL.: Influence of Ganoderma lucidum on blood biochemistry and immunocompetence in horses. Am J Chin Med 32, 931-940, 2004.
28. Lin ZB.: Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 99, 144-153, 2005.
29. Zhu XL., Chen AF., and Lin ZB.: Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 111, 219-226, 2007.
30. Yang G., Jiang RZ., Chen YH., Luo HM., Xu DD, et al.: Characterization and anti-tumor activity of glycopeptides from Ganoderma sinensis. Chem Res Chin Univ 25, 47-51, 2009.
31. Yang GH., Yang YF., and Jin JD.: Antitumor fraction from liquid submerged fermentation of Ganoderma sinense. Chin Tradit Herbal Drugs 39, 877-880, 2008.
32. Han XQ., Chan BCL., Dong CX., Yang YH., Ko CH, et al.: Isolation, structure characterization, and immunomodulating activity of a hyperbranched polysaccharide from the fruiting bodies of Ganoderma sinense. J Agric Food Chem 60, 4276-4281, 2012.
33. Han XQ., Chan BCL., Yu H., Yang YH., Hu SQ, et al.: Structural characterization and immuno-modulating activities of a polysaccharide from Ganoderma sinense. Int J Biol Macromol 51, 597-603, 2012.
34. Yue GGL., Chan BCL., Han XQ., Cheng L., Wong ECW, et al.: Immunomodulatory activities of Ganoderma sinense polysaccharides in human immune cells. Nutr Cancer 65, 765-774, 2013.
35. Klimp AH., De Vries EGE., Scherphof GL., and Daemen T.: A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol/Hematol 44, 143-161, 2002.
36. Zhang J., Tang Q., Zhou C., Jia W., Da Silva L, et al.: GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumour activity by increasing both humoral and cellular immune response. Life Sci 87, 628-637, 2010.
37. Zhao L., Dong Y., Chen G., and Hu Q.: Extraction, purification, characterization and antitumor activity of polysaccharides from Ganoderma lucidum. Carbohydr Polym 80, 783-789, 2010.
38. Dubois M., Gilles KA., Hamilton JK., Rebers PA., and Smith F.: Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350-356, 1956.
39. Xie J., Zhao J., Hu DJ., Duan JA., Tang YP, et al.: Comparison of polysaccharides from two species of Ganoderma. Molecules 17, 740-752, 2012.
40. Guan J., Yang FQ., and Li SP.: Evaluation of carbohydrates in natural and cultured Cordyceps by pressurized liquid extraction and gas chromatography coupled with mass spectrometry. Molecules 15, 4227-4241, 2010.
41. Bonavida B., Baritaki S., Huerta-Yepez S., Vega MI., Chatterjee D, et al.: Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo-and immunosensitization to apoptosis and inhibition of metastases. Nitric Oxide 19, 152-157, 2008.
42. Steinkamp JA., Wilson JS., Saunders GC., and Stewart CC.: Phagocytosis: Flow cytometric quantitation with fluorescent microspheres. Science 215, 64-66, 1982.
43. Onozaki K., Matsushima K., Aggarwal BB., and Oppenheim JJ.: Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 135, 3962-3968, 1985.
44. Lachman LB., Dinarello CA., Llansa ND., and Fidler IJ.: Natural and recombinant human interleukin 1-β is cytotoxic for human melanoma cells. J Immunol 136, 3098-3102, 1986.
45. Braddock M. and Quinn A.: Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov 3, 330-339, 2004.
46. Houssiau F. and Van Snick J.: IL6 and T-cell response. Res Immunol 143, 740-743, 1992.
47. Mocellin S., Marincola FM., and Young HA.: Interleukin-10 and the immune response against cancer: a counterpoint. J Leukocyte Biol 78, 1043-1051, 2005.
48. Dennis KL., Blatner NR., Gounari F., and Khazaie K.: Current status of interleukin-10 and regulatory T-cells in cancer. Curr Opin Oncol 25, 637-645, 2013.
49. Van Horssen R., Ten Hagen TLM., and Eggermont AMM.: TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11, 397-408, 2006.
50. Gao Y., Zhou S., Jiang W., Huang M., and Dai X.: Effects of Ganopoly® (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32, 201-215, 2003.
51. Aderem A. and Underhill DM.: Mechanisms of phagocytosis in macrophages. Annu Rev 17, 593-623, 1999.
52. Chokri M., Freudenberg M., Galanos C., Poindron P., and Bartholeyns J.: Antitumoral effects of lipopolysaccharides, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res 9, 1185-1190, 1989.
53. Kuo HP., Wang CH., Huang KS., Lin HC., Yu CT, et al.: Nitric oxide modulates interleukin-1β and tumor necrosis factor-α synthesis by alveolar macrophages in pulmonary tuberculosis. Am J Respir Crit Care Med 161, 192-199, 2000.
54. Hill JR., Corbett JA., Kwon G., Marshall CA., and McDaniel ML.: Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem 271, 22672-22678, 1996.
55. Eigler A., Sinha B., and Endres S.: Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Commun 196, 494-501, 1993.
56. Zhang M., Cui SW., Cheung PCK., and Wang Q.: Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Tech 18, 4-19, 2007.
57. Guan J. and Li SP.: Discrimination of polysaccharides from traditional Chinese medicines using saccharide mapping-Enzymatic digestion followed by chromatographic analysis. J Pharm Biomed Anal 51, 590-598, 2010.